Thank you to all the meeting organizers, presenters, moderators, and participants who attended the 2025 I-SCORE Meeting on March 27th! With 82 in person attendants and 48 virtual attendants, This meeting provides a great opportunity for information…

Thank you to all the meeting organizers, presenters, moderators, and participants who attended the 2024 I-SCORE Meeting on March 14th and 15th! With 89 in person attendants and 106 virtual attendants, 195 people attended from all over the world. This…

Dr. Eva Szabo presented the renewal of CP-CTNet at the BSA meeting on March 20, 2024. View Dr. Szabo’s presentation slides. The board was presented with justification for continuation of the program and key program changes. Upon approval a future…

Thank you to all the meeting organizers, presenters, moderators, and participants who attended the 2023 I-SCORE Meeting on March 30th and 31st! With 87 in person attendants and 125 virtual attendants, 212 people attended from all over the world. This…

Thank you to all the meeting organizers, presenters, moderators and participants who attended the 2022 I-SCORE Meeting on March 31st and April 1st! Despite a change to a virtual format again, over 160 people attended from all over the world. The…

The Office of Disease Prevention (ODP) is seeking nominations for its 2022 Early-Stage Investigator Lecture. The award is made annually to early-career scientists who have made significant research contributions in disease prevention but who have not…

The National Cancer Institute (NCI) has released three notices of intent to publish Funding Opportunity Announcements (FOAs) that will invite applications for a new initiative, the HIV/Cervical Cancer Prevention CASCADE Clinical Trials Network. The…

Thank you to all the meeting organizers, presenters, moderators and participants who attended the 2021 I-SCORE Meeting on April 29th and 30th! Despite a change to a virtual format again, over 140 people attended from all over the world. The meeting…

The University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet) has enrolled the first participant onto a CP-CTNet trial, An Extended Follow-up Study of the HPV Vaccine Delayed Booster Trial (UAZ20-01-02). This is a follow-up study…

The Translational Advances in Cancer Prevention Agent Development Meeting will be held virtually on August 27 and 28, 2020. Meeting Objectives: The main goals of this meeting are to: 1) Foster the exchange of ideas and potentially new collaborative…